| scholarly article | Q13442814 |
| P50 | author | Judith Lee Black | Q114084648 |
| P2093 | author name string | Janette K Burgess | |
| Lyn M Moir | |||
| Qi Ge | |||
| Maree H Poniris | |||
| P2860 | cites work | Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma | Q24245383 |
| Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma | Q24245643 | ||
| Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). | Q33922403 | ||
| Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells | Q38338087 | ||
| Collagen remodelling by airway smooth muscle is resistant to steroids and β₂-agonists | Q39686023 | ||
| Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts | Q40036240 | ||
| Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells | Q40075030 | ||
| Lung fibroblast proteoglycan production induced by serum is inhibited by budesonide and formoterol | Q42484059 | ||
| Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts | Q43059932 | ||
| Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids | Q43517296 | ||
| Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma | Q43660405 | ||
| Airway smooth muscle cell proliferation is increased in asthma | Q43704206 | ||
| Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling | Q44203474 | ||
| Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism | Q44853680 | ||
| Opposite effect of fluticasone and salmeterol on fibronectin and tenascin-C expression in primary human lung fibroblasts. | Q46077287 | ||
| Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix | Q46650411 | ||
| Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB. | Q46739918 | ||
| Transforming growth factor beta 1 increases fibronectin deposition through integrin receptor alpha 5 beta 1 on human airway smooth muscle | Q46776251 | ||
| Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group | Q49092631 | ||
| Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. | Q54798238 | ||
| Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids | Q71078827 | ||
| Caldesmon, calponin and alpha-smooth muscle actin expression in subcultured smooth muscle cells from human airways | Q72376140 | ||
| Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group | Q72684559 | ||
| The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone | Q73286292 | ||
| Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells | Q73937687 | ||
| Opposite effect of corticosteroids and long-acting beta(2)-agonists on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts | Q79169473 | ||
| Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle | Q80175364 | ||
| A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro | Q80207159 | ||
| Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle | Q81250895 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | extracellular matrix | Q193825 |
| P304 | page(s) | 403059 | |
| P577 | publication date | 2012-02-08 | |
| P1433 | published in | Journal of Allergy | Q24039111 |
| P1476 | title | Combined Beta-agonists and corticosteroids do not inhibit extracellular matrix protein production in vitro | |
| P478 | volume | 2012 |
| Q89397425 | A theoretical model of inflammation- and mechanotransduction-driven asthmatic airway remodelling | cites work | P2860 |
Search more.